NEUCHATEL, Switzerland–(BUSINESS WIRE)–Masimo (NASDAQ: MASI) today announced Dual SET® Pulse Oximetry for Root®, a highly versatile patient monitoring and connectivity hub. The first application of Dual SET® Oximetry is a significant advancement to Masimo SET®-guided critical congenital heart disease (CCHD) screening, with the CE marking and European launch of the Masimo SET® MOC-9® module and […]
Coronary/Structural Heart
HeartFlow Analysis is First AI-Enabled Technology to be Recognized by the American College of Cardiology and American Heart Association Guidelines as an Important Tool in Diagnosing and Treating Heart Disease
Chest Pain Guidelines also elevate coronary CT as the only first-line test for many patients REDWOOD CITY, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) — HeartFlow, Inc., the leader in revolutionizing precision heart care, today welcomed new clinical practice guidelines from the American College of Cardiology (ACC) and American Heart Association (AHA) that recognized […]
Cytokinetics Announces Preclinical Data Relating to CK-3828136 Presented at the 2021 Medicinal Chemistry Gordon Research Conference
SOUTH SAN FRANCISCO, Calif., Oct. 29, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that preclinical data relating to the discovery and optimization of CK-3828136 (CK-136) were presented at the 2021 Medicinal Chemistry Gordon Research Conference in West Dover, VT. CK-136 is a novel, selective cardiac troponin activator […]
HT Supreme® Drug Eluting Stent performs equivalent to best-in-class in the PIONEER III publication
TIANJIN, China, Oct. 27, 2021 /PRNewswire/ — SINOMED, a leading international medical device company, announced that the clinical trial results for its HT Supreme® Drug-Eluting Stent (DES) System has been published in Circulation. The article described results from the PIONEER III trial where investigators demonstrated equivalence in safety and effectiveness between the […]
Encouraging outcomes observed in Europe for the TriGUARD 3™ Cerebral Embolic Protection Device During Transcatheter Heart Procedures
TAMPA, Fla., Oct. 27, 2021 /PRNewswire/ — Keystone Heart Ltd., a Venus Medtech Company, today announced a key milestone in Europe with the TriGUARD 3 Cerebral Embolic Protection (CEP) Device. The device was granted CE mark in March of 2020 and, since launch, utilized in fourteen countries with zero physician-reported strokes. The TriGUARD 3 CEP device is the only […]
One Drop Delivers Novel AI-Powered Solution For Cardiovascular Disease Prevention
Market availability of the cardiovascular disease prevention module co-developed with Bayer demonstrates One Drop’s continued expansion into new therapeutic areas NEW YORK, Oct. 27, 2021 /PRNewswire/ — One Drop, a leader in precision health solutions for people living with chronic conditions worldwide, today announced the release of a digital, AI-enabled cardiovascular disease […]
Teleflex Completes Enrollment in Cardiac IDE Study
Study Evaluates Effectiveness of QuikClot Control+® Hemostatic Device in Patients Undergoing Cardiac Surgery WAYNE, Pa., Oct. 27, 2021 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the completion of patient enrollment in a clinical study evaluating the performance of the QuikClot Control+® Hemostatic Device […]
Acarix granted US CPT reimbursement code for CADScor System
Malmö, Sweden, October 27, 2021 Acarix granted US CPT reimbursement code for CADScor System The editorial panel of the American Medical Association (AMA) today approved the Category III CPT® (CPT III) code application for the Acarix CADScor System®. The application was actively endorsed by the American College of Cardiology (ACC) […]
The American Society for Preventive Cardiology Publishes Clinical Practice Statement on Improving the Enrollment of Women and Racially/Ethnically Diverse Populations in Cardiovascular Clinical Trials
JACKSONVILLE, Fla., Oct. 26, 2021 /PRNewswire/ — The American Society for Preventive Cardiology (ASPC) has recently published a Clinical Practice Statement in the American Journal of Preventive Cardiology: Improving the Enrollment of Women and Racially/Ethnically Diverse Populations in Cardiovascular Clinical Trials. An ASPC working group was formed, chaired by Dr. Erin Michos and Dr. Keith […]
Coreline AI Coronary Artery Calcium Solution Shows 99.2% Accuracy From a Population Study
SEOUL, South Korea–(BUSINESS WIRE)–Coreline Soft, the developer of the AI Coronary Artery Calcium (CAC) solution named AVIEW CAC, announced that its AI CAC solution showed 99.2% accuracy from a population study conducted by the Institute for Diagnostic Accuracy (iDNA), the NELSON trial team in Europe. The study verified the performance of […]



